Moors & Cabot, Inc. Mckesson Corp Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Mckesson Corp stock. As of the latest transaction made, Moors & Cabot, Inc. holds 2,861 shares of MCK stock, worth $1.66 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,861

Previous 2,448 16.87%

Holding current value

$1.66 Million

Previous $1.43 Million 1.12%

% of portfolio

0.07%

Previous 0.08%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$479.06 - $630.38 $197,851 - $260,346	413 Added 16.87%	2,861 $1.41 Million
Q2 2024 Aug 09, 2024	BUY	$518.81 - $607.81 $84,566 - $99,073	163 Added 7.13%	2,448 $1.43 Million
Q1 2024 May 08, 2024	BUY	$473.42 - $539.26 $28,405 - $32,355	60 Added 2.7%	2,285 $1.23 Million
Q4 2023 Feb 14, 2024	BUY	$437.42 - $470.64 $131,226 - $141,192	300 Added 15.58%	2,225 $1.03 Million
Q3 2023 Nov 07, 2023	BUY	$402.4 - $446.42 $53,116 - $58,927	132 Added 7.36%	1,925 $837,000
Q2 2023 Aug 09, 2023	BUY	$354.01 - $427.31 $54,517 - $65,805	154 Added 9.4%	1,793 $766,000
Q1 2023 May 04, 2023	SELL	$335.35 - $386.06 $8,383 - $9,651	-25 Reduced 1.5%	1,639 $583,000
Q4 2022 Feb 09, 2023	BUY	$346.68 - $397.58 $576,875 - $661,573	1,664 New	1,664 $624,000
Q3 2022 Nov 07, 2022	BUY	$321.25 - $373.84 $37,265 - $43,365	116 Added 6.9%	1,797 $611,000
Q2 2022 Aug 08, 2022	SELL	$300.57 - $336.42 $81,755 - $91,506	-272 Reduced 13.93%	1,681 $548,000
Q1 2022 May 13, 2022	SELL	$244.61 - $310.48 $2.95 Million - $3.74 Million	-12,047 Reduced 86.05%	1,953 $598,000
Q3 2021 Nov 05, 2021	BUY	$188.42 - $208.66 $2.64 Million - $2.92 Million	14,000 New	14,000 $15,000

Others Institutions Holding MCK

# of Institutions

1,690

Shares Held

108M

Call Options Held

1.66M

Put Options Held

968K

View Full List

About MCKESSON CORP

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $83.2B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

More about MCK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account